|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The role c-reactive protein in cardiovascular disease risk 显示文摘 | Albert MA Ridker PM | 1999 | Curr Cardio Rep1999，1，2： | 1 |
| 2 | Plasma concentration of C2reactive proteinand the calculated Framingham coronary heart disease risk score显示文摘 | Albert MA Glynn R J Ridker PM | 2003 | Circulation2003，108，： | 1 |
| 3 | C-reactive protein as a risk predictor: Do race/ethnicity and gender make a difference? 显示文摘 | Albert MA Ridker PM | 2006 | Circulation2006，114，5： | 1 |
| 4 | The role of C-reactive protein in cardiovascular risk显示文摘 | Albert MA Ridker PM | 1999 | Curr Cardiol Rep1999，1，2： | 1 |
| 5 | The role of C-reactive protein in cardiovascular disease risk显示文摘 | Albert MA Ridker PM | 1999 | Curr Cardiol Rep1999，1，2： | 1 |
| 6 | Alcohol consumption and plasma concen- tration of C-reactive protein 显示文摘 | Albert MA Glynn R J Ridker PM | 2003 | Circulation2003，107，3： | 1 |
| 7 | Alcohol consumption and plasma concentration of C-reactive protein 显示文摘 | Albert MA Glynn R J Ridker PM | 2003 | Circulation2003，107，： | 1 |
| 8 | C-Reactive Protein as a Risk Predictor:Do Race/Ethnicity and Gender Make a Difference显示文摘 | Albert MA Ridker PM | 2006 | Circulation2006，114，5： | 1 |
| 9 | Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma:a North Central Cancer Treatment Group phase II study 显示文摘 | Alberts SR Townley PM Goldberg RM | 2003 | Ann Oncol2003，14，4： | 1 |
| 10 | Sudden cardiac death,genes,and arrhythmogenesis:consideration of new population,and mechanistic approaches from an National Heart,Lung,and Blood Institute workshop:part 1显示文摘 | Spooner PM Albert C Benjamin EJ | 2001 | Circulation2001，103，： | 1 |
| 11 | Sudden cardiac death,genes,and arrhythmogenesis: consideration of new population,and mechanistic approaches from an National Heart,Lung,and Blood Institute workshop:part 2 显示文摘 | Spooner PM Albert C Benjamin EJ | 2001 | Circulation2001，103，： | 1 |
| 12 | Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma:a North Central Cancer Treatment Group phase Ⅱ study 显示文摘 | Alberts SR Townley PM Goldberg RM | 2003 | Ann Oncol2003，14，4： | 1 |
| 13 | Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Cantral Cancer Treatment Group phase Ⅱ study 显示文摘 | Alberts SR Townley PM Goldberg RM | 2003 | Ann Oncol2003，14，4： | 1 |
| 14 | Gemcitabine and oxaliplatn for patients with advanced or metastatic pancreatic cancer:a North Central Cancer Treatemnt Group (NCCNG) phase Ⅰ study显示文摘 | Alberts SR Townley PM Goldberg RM | | 0，，： | 1 |
| 15 | C-reactive protein as a risk predictor do race/ethnicity and gender make a difference显示文摘 | Albert MA Ridker PM | 2006 | Circulation2006，114，： | 1 |
| 16 | Sudden cardiac death,genes,and arrhythmogenesis: consideration of new pop- ulation and mechanistic approaches from a national heart, lung, and blood institute workshop, part I显示文摘 | Spooner PM Albert C Benjamin EJ | 2001 | Circulation2001，103，19： | 1 |
| 17 | Plasma concentration of C - re- active protein and the calculated Framingham Coronary Heart Dis- ease Risk Score显示文摘 | Albert MA Glynn RJ Ridker PM | 2003 | Circulation2003，108，2： | 1 |
| 18 | Sudden cardiac death,genes,and arrhythmogenesis:consideration of new population and mechanistic approaches from a national heart lung,and blood institute workshop,part I显示文摘 | Spooner PM Albert C Benjamin EJ | | 0，，19： | 1 |
| 19 | Double-blind cross-over study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide显示文摘 | Aapro MS Plezia PM Alberts DS | 1984 | J Clin Oncology1984，2，： | 1 |
| 20 | Gemcitabine and oxalipatin for patients with advanced or metastatic pancreatic cancer:a North central cancer Treatment Group (NCCTG) phase Ⅰ study 显示文摘 | Alberts SR Townley PM Goldberg RM | 2002 | Ann Oncol2002，，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员